List of Rohto Pharmaceutical patents

Patents where

Current Assignee

Name

Rohto Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11273437 Cell treatment apparatus		Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	11273437	March 15, 2022
‌ US Patent 9345779 Aqueous ophthalmic composition	Patent 9345779 was granted and assigned to Rohto Pharmaceutical on May, 2016 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	9345779	May 24, 2016
‌ US Patent 8067038 Ophthalmic composition for soft contact lens comprising terpenoid	Patent 8067038 was granted and assigned to Rohto Pharmaceutical on November, 2011 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	8067038	November 29, 2011
‌ US Patent 9034931 Aqueous ophthalmic composition	Patent 9034931 was granted and assigned to Rohto Pharmaceutical on May, 2015 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	9034931	May 19, 2015
‌ US Patent 9724312 Agent for the prevention, improvement or treatment of retinal disease	Patent 9724312 was granted and assigned to Rohto Pharmaceutical on August, 2017 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	9724312	August 8, 2017
‌ US Patent 7989590 Peptides that increase collagen or hyaluronic acid production	Patent 7989590 was granted and assigned to Rohto Pharmaceutical on August, 2011 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	7989590	August 2, 2011
‌ US Patent 11331390 Ophthalmic composition	Patent 11331390 was granted and assigned to Rohto Pharmaceutical on May, 2022 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	11331390	May 17, 2022
‌ US Patent 11253550 Method for treating fibrotic liver disease	Patent 11253550 was granted and assigned to Rohto Pharmaceutical on February, 2022 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	11253550	February 22, 2022
‌ US Patent RE43583 Ophthalmic composition for soft contact lens comprising terpenoid	Patent RE43583 was granted and assigned to Rohto Pharmaceutical on August, 2012 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	RE43583	August 14, 2012
‌ US Patent 9278062 Eye drops	Patent 9278062 was granted and assigned to Rohto Pharmaceutical on March, 2016 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	9278062	March 8, 2016
‌ US Patent 9427473 Aqueous ophthalmic composition	Patent 9427473 was granted and assigned to Rohto Pharmaceutical on August, 2016 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	9427473	August 30, 2016
‌ US Patent 9675538 Anti-aging agent containing arctigenin derivative	Patent 9675538 was granted and assigned to Rohto Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	9675538	June 13, 2017
‌ US Patent 8669241 Ophthalmic composition	Patent 8669241 was granted and assigned to Rohto Pharmaceutical on March, 2014 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	8669241	March 11, 2014
‌ US Patent 9050369 Aqueous ophthalmic composition	Patent 9050369 was granted and assigned to Rohto Pharmaceutical on June, 2015 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	9050369	June 9, 2015
‌ US Patent 9320802 Aqueous ophthalmic composition	Patent 9320802 was granted and assigned to Rohto Pharmaceutical on April, 2016 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	9320802	April 26, 2016
‌ US Patent D903861 Eye drop container	Patent D903861 was granted and assigned to Rohto Pharmaceutical on December, 2020 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D903861	December 1, 2020
‌ US Patent D882075 Child-proof cap for an eye drop container	Patent D882075 was granted and assigned to Rohto Pharmaceutical on April, 2020 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D882075	April 21, 2020
‌ US Patent D840821 Child-proof eye drop container	Patent D840821 was granted and assigned to Rohto Pharmaceutical on February, 2019 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D840821	February 19, 2019
‌ US Patent 8754029 Ophthalmic composition	Patent 8754029 was granted and assigned to Rohto Pharmaceutical on June, 2014 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	8754029	June 17, 2014
‌ US Patent D841153 Child-proof cap for an eye drop container	Patent D841153 was granted and assigned to Rohto Pharmaceutical on February, 2019 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D841153	February 19, 2019
‌ US Patent D829555 Child-proof eye drop container	Patent D829555 was granted and assigned to Rohto Pharmaceutical on October, 2018 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D829555	October 2, 2018
‌ US Patent D845776 Container	Patent D845776 was granted and assigned to Rohto Pharmaceutical on April, 2019 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	D845776	April 16, 2019
‌ US Patent 10835572 Composition for external application	Patent 10835572 was granted and assigned to Rohto Pharmaceutical on November, 2020 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	10835572	November 17, 2020
‌ US Patent D570696 Container	Patent D570696 was granted and assigned to Rohto Pharmaceutical on June, 2008 by the United States Patent and Trademark Office.		Rohto Pharmaceutical	United States Patent and Trademark Office	D570696	June 10, 2008
‌ US Patent 10842875 Ophthalmic composition	Patent 10842875 was granted and assigned to Rohto Pharmaceutical on November, 2020 by the United States Patent and Trademark Office.	Rohto Pharmaceutical	Rohto Pharmaceutical	United States Patent and Trademark Office	10842875	November 24, 2020

Results per page:

29 results

0 selected

29 results

0 selected